Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
14 studies found for:    bapineuzumab
Show Display Options
RSS Create an RSS feed from your search for:
bapineuzumab
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Experimental Bapineuzumab
2 Terminated AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab (AAB-001)
3 Terminated
Has Results
A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients
Condition: Alzheimer Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Bapineuzumab 1.0 m/kg
4 Terminated
Has Results
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab;   Drug: placebo
5 Terminated Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab
Condition: Alzheimer Disease
Intervention: Drug: bapineuzumab
6 Terminated
Has Results
A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
Condition: Alzheimer Disease
Intervention: Drug: Bapineuzumab 0.5 mg/kg
7 Terminated
Has Results
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab;   Drug: placebo
8 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
9 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
10 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
11 Completed
Has Results
Study Evaluating Bapineuzumab In Alzheimer Disease Subjects
Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab;   Drug: placebo
12 Terminated Retrieval of Patient Information After Discontinuation
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
13 Completed
Has Results
Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease
Condition: Alzheimer Disease
Intervention: Drug: bapineuzumab
14 Completed AAB-001 in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: bapineuzumab;   Other: placebo

Study has passed its completion date and status has not been verified in more than two years.